Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.450
+0.050 (3.57%)
Mar 9, 2026, 2:52 PM EDT - Market open
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $199.64 million as of March 9, 2026. Its market cap has increased by 141.66% in one year.
Market Cap
199.64M
Enterprise Value
168.71M
1-Year Change
141.66%
Ranking
Category
Stock Price
$1.45
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $199.64M, a decrease of -61.17%. That is a compound annual growth rate of -19.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 192.76M | 28.44% |
| Dec 31, 2025 | 150.07M | 230.61% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CVRx, Inc. | 217.07M |
| Sight Sciences | 200.36M |
| Owlet | 200.24M |
| SANUWAVE Health | 198.71M |
| Electromed | 197.61M |
| InfuSystem Holdings | 191.64M |
| Profound Medical | 188.69M |
| Nano-X Imaging | 186.87M |